Skip to main content

Sexual health lidocaine 2.5% plus prilocaine 2.5% cream (EMLA Cream 5%, Nulbia 5% cream) to facilitate intrauterine contraception (IUC) insertion or removal

Rotherham, Doncaster and South Humber NHS Foundation Trust (RDaSH) patient group direction (PGD) for the administration of topical lidocaine 2.5% plus prilocaine 2.5% cream (EMLA Cream 5% or Nulbia 5% cream) to facilitate intrauterine contraception (IUC) insertion or removal.

This template protocol, for local adaptation, has been peer reviewed by the reproductive health PGD protocols short life working group in accordance with their terms of reference. It has been approved by the faculty for sexual and reproductive health (FSRH) in November 2022.

To download this PGD please follow the link: Lidocaine plus prilocaine cream (staff access only) (opens in new window).

To access the equality impact assessment for this policy, please see the overarching equality impact assessment.

Page last reviewed: January 17, 2025
Next review due: January 17, 2026

Problem with this page?

Please tell us about any problems you have found with this web page.

Report a problem